LEADER 01984nam  22006014a 450 
001 9910449948503321
005 20200520144314.0
010   $a0-471-72327-4
010   $a1-280-25506-4
010   $a9786610255061
010   $a0-471-72326-6
035   $a(CKB)1000000000244119
035   $a(SSID)ssj0000150829
035   $a(PQKBManifestationID)11144511
035   $a(PQKBTitleCode)TC0000150829
035   $a(PQKBWorkID)10317915
035   $a(PQKB)10185648
035   $a(MiAaPQ)EBC231747
035   $a(Au-PeEL)EBL231747
035   $a(CaPaEBR)ebr10114176
035   $a(CaONFJC)MIL25506
035   $a(OCoLC)936897231
035   $a(EXLCZ)991000000000244119
100   $a20041005d2005      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aEvaluation of enzyme inhibitors in drug discovery$b[electronic resource] $ea guide for medicinal chemists and pharmacologists /$fRobert A. Copeland
210   $aHoboken, N.J. $cWiley-Interscience$d2005
215   $axvii, 271 p. $cill
225 1 $aMethods of biochemical analysis ;$vv. 46
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-471-68696-4 
320   $aIncludes bibliographical references and index.
410  0$aMethods of biochemical analysis ;$vv. 46.
606   $aEnzyme inhibitors$xTherapeutic use$xTesting
606   $aDrugs$xDesign
606   $aEnzyme inhibitors$xStructure-activity relationships
608   $aElectronic books.
615  0$aEnzyme inhibitors$xTherapeutic use$xTesting.
615  0$aDrugs$xDesign.
615  0$aEnzyme inhibitors$xStructure-activity relationships.
676   $a615/.19
700   $aCopeland$b Robert Allen$0478630
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910449948503321
996   $aEvaluation of enzyme inhibitors in drug discovery$91489960
997   $aUNINA